Open AccessEfficiency of L-arginin in arterial hypertension
Author(s) -
V.K. Taschuk,
L. І. Vlasyk,
Halyna Khrebtii
Publication year - 2019
Publication title -
êdine zdorov'â ta problemi harčuvannâ ukraïni
Language(s) - English
Resource type - Journals
eISSN - 2664-0694
pISSN - 2663-9726
DOI - 10.33273/2663-9726-2019-50-1-75-79
Subject(s) - atorvastatin , hypertriglyceridemia , medicine , nitric oxide , insulin resistance , tonicity , arginine , vasodilation , endothelium , cardiology , pharmacology , insulin , endocrinology , amino acid , cholesterol , chemistry , biochemistry , triglyceride
The effectiveness of the new treatment scheme of the patients with hypertonic disease accompanied by insulin resistance by adding to the treatment L-arginine — the predecessor of nitric oxide has been examined in this work. The average duration of the research was 3 months. Including a conditionally essential amino acid L-arginine to a combined antihypertensive therapy with the help of lisinopil and amplodipine and to hypolipidemic therapy with atorvastatin had significant benefits in increasing endothelium dependent vasodilatation, decreasing HOMA-index and also in more effective correction of hypertriglyceridemia.